Subscribe to RSS
Download PDF
DOI: 10.1055/a-2113-5884
Digitale Erfassung der Krankheitsaktivität – Einblicke in ein Versorgungsforschungsprojekt.
Digital Recording of Disease Activity: Insights into a Health Services Research Project
Zusammenfassung
Eine digitale Erfassung der Krankheitsaktivität mittels sogenannter Gesundheits-Apps ist in der Rheumatologie valide möglich. Die routinemäßige Verwendung von electronic patient-reportedoutcomes(ePRO) vor bzw. während einer Präsenzvisite ist hinsichtlich Datenäquivalenz gut untersucht. Vorgestellt wird ein Versorgungsforschungsprojekt, das zeigte, dass ein regelmäßiger ePRO Export bei axSpA Patienten mit hoher Krankheitsaktivität angewendet werden kann und dass kein signifikanter Unterschied zwischen digitalen und papierbasierten Scores bestand– die Patientenselektion muss jedoch noch besser spezifiziert werden. Neben den Vorteilen einer Gesundheits-App zur Überwachung und Therapiesteuerung sind in der Nutzung von Gesundheits-Apps Hürden insbesondere im Bereich der Patientenselektion, der Verfügbarkeit einer Gesundheits-App und mögliche negative Einflüsse durch eine ggf. niedrige Gesundheitskompetenz zu beachten. Gesundheits-Apps weisen eine Vielzahl an vielversprechenden Funktionen und Effekten auf, die im Sinne des DiGA Verzeichnisses noch nicht alle hinsichtlich der langfristigen Wirksamkeit und des Einflusses auf die Versorgungsrealität untersucht sind.
Abstract
Valid digital recording of disease activity via health apps is possible in rheumatology. The routine use of electronic patient-reported outcomes (ePRO) before or during an office visit has been well studied in terms of data equivalence. This study presents a health services research project which shows that a regular ePRO export can be used in axSpA patients with high disease activity – but patient selection needs to be better specified. In addition to the benefits of a health app for monitoring and therapy management, there are hurdles to consider in the use of health apps, particularly with a view to patient selection, availability of a health app, and potential negative influences due to low (e)health literacy. Health apps show a variety of promising functions and effects, which, in terms of the DiGA directory, have not all been investigated as yet with regard to long-term effectiveness and influence on the reality of care. There is clearly a need for further research.
Publication History
Article published online:
04 August 2023
© 2023. Thieme. All rights reserved.
Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart,
Germany
-
Literatur
- 1 Kiltz U, Braun J, Dgrh, et al. Long version on the S3 guidelines for axial spondyloarthritis including Bechterew’s disease and early forms, Update 2019: Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations. Z Rheumatol 2019; 78: 3-64
- 2 Kiltz U, Buschhorn-Milberger V, Albrecht K. et al. Development of quality standards for patients with axial spondyloarthritis for use in Germany. Z Rheumatol. 2022
- 3 Kiltz U, Landewe RBM, van der Heijde D. et al. Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis. Ann Rheum Dis 2020; 79: 193-201
- 4 Uhrenholt L, Christensen R, Dreyer L. et al. Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial. Scand J Rheumatol 2023; 1-12
- 5 Garrett S, Jenkinson T, Kennedy LG. et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286-2291
- 6 Machado P, Landewe R, Lie E. et al. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 2011; 70: 47-53
- 7 Lukas C, Landewe R, Sieper J. et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009; 68: 18-24
- 8 Kiltz U, Boonen A, Braun J. et al. Electronic assessment of disease activity and functioning in patients with axial spondyloarthritis: challenges and unmet needs. Clin Exp Rheumatol 2016; 34: S57-S61
- 9 RheMIT – Dokumentationssoftware für die Rheumatologie: https://www.bdrh.de/praxismanagement/rhemit/, 2023
- 10 Callhoff J, Feuchtenberger M, Karberg K. et al Mit RheMIT können Rheumazentren an der bundesweiten Kerndokumentation teilnehmen – Erweiterung der rheumatologischen Langzeitdokumentation. Zeitschrift fuer Rheumatologie. 2023 submitted.
- 11 Richter JG, Nannen C, Chehab G. et al. Mobile App-based documentation of patient-reported outcomes – 3-months results from a proof-of-concept study on modern rheumatology patient management. Arthritis Res Ther 2021; 23: 121
- 12 Richter JG, Chehab G, Kiltz U. et al. Identification of rheumatological health apps in the Apple app store applying the “semiautomatic retrospective app store analysis” method: A longitudinal observation. Z Rheumatol. 2021
- 13 https://www.apple.com/de/app-store/ https://play.google.com/store/apps/details?id=org.asas_group.asdas_calculator&hl=de&gl=US 2023
- 14 https://www.egms.de/static/de/meetings/dgrh2019/19dgrh280.shtml] 2023
- 15 Rautenstrauch J, Richter J, Specker C. et al. Presentation of the Dusseldorf Competence Center. Z Rheumatol 2001; 60: 361-366
- 16 Whitepaper DocuMed.rh. 2007. Accessed 30.03.2023.
- 17 Solomon DH, Rudin RS. Digital health technologies: opportunities and challenges in rheumatology. Nat Rev Rheumatol 2020; 16: 525-535
- 18 Seppen B, Wiegel J, Ter Wee MM. et al. Smartphone-Assisted Patient-Initiated Care Versus Usual Care in Patients With Rheumatoid Arthritis and Low Disease Activity: A Randomized Controlled Trial. Arthritis Rheumatol 2022; 74: 1737-1745
- 19 Uhrenholt L, Christensen R, Dreyer L. et al. Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis: A randomized, crossover, agreement study. Scand J Rheumatol 2022; 51: 25-33
- 20 Knitza J, Simon D, Lambrecht A. et al. Mobile Health Usage, Preferences, Barriers, and eHealth Literacy in Rheumatology: Patient Survey Study. JMIR mHealth and uHealth 2020; 8: e19661
- 21 Ramiro S, Nikiphorou E, Ortolan A. et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 2023; 82: 19-34
- 22 Hermans K. et al. Effectiveness and cost-effectiveness of combined asynchronous telemonitoring and patient-initiated care for spondyloarthritis: protocol for a pragmatic multicentre randomized controlled trial (TeleSpA Study). BMJ Open 2023; 13: e067445
- 23 Labinsky H, Gupta L, Raimondo M-G. et al. Real‑world usage of digital health applications (DiGA) in rheumatology: results from a German patient survey. Rheumatology International 2023; 43: 713-719
- 24 Knitza J. et al. Accuracy and tolerability of self-sampling of capillary blood for analysis of inflammation and autoantibodies in rheumatoid arthritis patients – results from a randomized controlled trial Arthritis Research & Therapy 2022; 24: 125